A province-wide childhood malignancy profiles in Indonesia (2010-2019): Yogyakarta Pediatric Cancer Registry

Eddy Supriyadi; Ignatius Purwanto; Inggar Armytasari; Julie Ritter; Pudjo Hagung Widjajanto; Anjo JP Veerman

doi:10.14238/pi63.4.2023.226-37

Eddy Supriyadi Department of Pediatric Hematology-Oncology, Dr. Sardjio Hospital - Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada, Yogyakarta, Indonesia
Ignatius Purwanto Department of Pediatric Hematology-Oncology, Dr. Sardjio Hospital - Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada, Yogyakarta, Indonesia
Inggar Armytasari Department of Pediatric, Dr. Sardjito Hospital - Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada, Yogyakarta, Indonesia
Julie Ritter Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA
Pudjo Hagung Widjajanto Department of Pediatric Hematology-Oncology, Dr. Sardjio Hospital - Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada, Yogyakarta, Indonesia
Anjo JP Veerman Vrije Universiteit Amsterdam, the Netherlands

DOI: https://doi.org/10.14238/pi63.4.2023.226-37

Keywords: Epidemiology, Leukemia, Indonesia, Pediatric oncology, Registries, Retinoblastoma

Abstract

Background The global burden of childhood cancer is poorly quantified, but it is estimated that 80% of all children with cancer live in low- and middle-income countries with cure rates of childhood cancer far lower than in high-income nations.

Objective To describe the Yogyakarta Region pediatric cancer profile from 2010-2019 and compare it to that of a 2000-2009 study in the same setting.

Methods This retrospective study of childhood cancer was conducted in patients aged £18 years and diagnosed in Dr. Sardjito General Hospital from 2010 to 2019. Pediatric cancer patient data were collected from hospital hardcopy and electronic medical records. An estimated annual average incidence rate of childhood cancer was calculated and the number of patients by their regions of origin were visualized. The number of childhood malignancies recorded is also compared by the number found in 2000-2009 study.

Results There were 1,839 new cases registered in Yogyakarta Pediatric Cancer Registry during the study period. The mean age at diagnosis was 6.3 years and male-to-female ratio was 1.4: 1.0. Fifty-six% of cancers were diagnosed in the 0-5-years age group. The most common diagnosis category was leukemia, which accounted for 60% of all childhood malignancies. The three most common diagnoses were acute lymphoblastic leukemia (44%), acute myeloid leukemia (12%), and retinoblastoma (7%). The annual average incidence rates of leukemia and solid tumors were 26.8 and 17.5 per million, respectively. The number of patients registered in 2000-2009 study was 1,124 case. Therefore, there was an increase of 63.6% in the number of childhood malignancies registered in 2010-2019 compared to the 2000-2009 study.

Conclusion There is an increase in the number of childhood malignancies registered in 2010-2019 compared to the 2000-2009 study. The number of patients referred to our hospital increased, indicating a more inclusive registry, better referral system, and better access to health care facility.

References

1. Ali K, Sutaryo S, Purwanto I, Mulatsih S, Supriyadi E, Widjajanto PH, et al. Yogyakarta Pediatric Cancer Registry: an international collaborative project of University Gadjah Mada, University of Saskatchewan, and the Saskatchewan Cancer Agency. Asian Pac J Cancer Prev. 2010 Jan 1;11(1):131-6. PMID: 20593943.
2. Bhakta N, Force LM, Allemani C, Atun R, Bray F, Coleman MP, et al. Childhood cancer burden: a review of global estimates. Lancet Oncol. 2019 Jan 1;20(1):e42-53. DOI: https://doi.org/10.1016/S1470-2045(18)30761-7.
3. Johnston WT, Erdmann F, Newton R, Steliarova-Foucher E, Schüz J, Roman E. Childhood cancer: estimating regional and global incidence. Cancer Epidemiol. 2021Apr 1;71:101662. DOI: https://doi.org/10.1016/j.canep.2019.101662.
4. Badan Pusat Statistik, BPS-Statistics Indonesia. Statistik Indonesia Statistical Yearbook of Indonesia 2018. Jakarta: Badan Pusat Statistik; 2018. p. 85. ISSN: 0126-2912.
5. Wahidin M, Noviani R, Hermawan S, Andriani V, Ardian A, Djarir H. Population-based cancer registration in Indonesia. Asian Pac J Cancer Prev. 2012;13(4):1709-10. DOI: https://doi.org/10.7314/apjcp.2012.13.4.1709.
6. Howard SC, Metzger ML, Wilimas JA, Quintana Y, Pui CH, Robison LL, et al. Childhood cancer epidemiology in low?income countries. Cancer. 2008 Feb 1;112(3):461-72. DOI: https://doi.org/10.1002/cncr.23205.
7. Supriyadi E, Widjajanto PH, Purwanto I, Cloos J, Veerman AJ, Sutaryo S. Incidence of childhood leukemia in Yogyakarta, Indonesia, 1998–2009. Pediatr Blood Cancer. 2011 Oct;57(4):588-93. DOI: https://doi.org/10.1002/pbc.23109.
8. Steliarova?Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer, third edition. Cancer. 2005;103(7):1457-67. DOI: https://doi.org/10.1002/cncr.20910.
9. Badan Pusat Statistik, BPS Provinsi D.I. Yogyakarta. Statistik Indonesia Statistical Yearbook of D.I. Yogyakarta Province 2014. Jakarta: Badan Pusat Statistik; 2014. p. 85. ISSN: 0126-2912.
10. Steliarova-Foucher E, Colombet M, Ries LA, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017 Jun 1;18(6):719-31. DOI: https://doi.org/10.1002/cncr.20910.
11. Bidwell SS, Peterson CC, Demanelis K, Zarins KR, Meza R, Sriplung H, et al. Childhood cancer incidence and survival in Thailand: a comprehensive population?based registry analysis, 1990–2011. Pediatr Blood Cancer. 2019 Jan;66(1):e27428. DOI: https://doi.org/10.1002/pbc.27428.
12. Williams LA, Richardson M, Marcotte EL, Poynter JN, Spector LG. Sex ratio among childhood cancers by single year of age. Pediatr Blood Cancer. 2019 Jun;66(6):e27620. DOI: https://doi.org/10.1002/pbc.27620.
13. Idris F, Anggraini M, Humaidi I, Ma’ruf MI, Rahmitasari R. Informasi BPJS: Menuju Jaminan Kesehatan Nasional 2019. Jakarta: BPJS Kesehatan; 2019. p. 6.
14. Jain M, Rojanaporn D, Chawla B, Sundar G, Gopal L, Khetan V. Retinoblastoma in Asia. Eye. 2019 Jan;33(1):87-96. DOI: https://doi.org/10.1038/s41433-018-0244-7
15. Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, et al. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2016 Feb 1;100(2):172-8. DOI: https://doi.org/10.1136/bjophthalmol-2015-306672.
16. Leander C, Fu LC, Peña A, Howard SC, Rodriguez?Galindo C, Wilimas JA, et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer. 2007 Nov;49(6):817-9. DOI: https://doi.org/10.1002/pbc.21052.
17. Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Atun R. Estimating the total incidence of global childhood cancer: a simulation-based analysis. Lancet Oncol. 2019 Apr 1;20(4):483-93. DOI: https://doi.org/10.1016/S1470-2045(19)30273-6.
18. Rutherford ME, Mulholland K, Hill PC. How access to health care relates to under?five mortality in sub?Saharan Africa: systematic review. Tropical Med Int Health. 2010 May;15(5):508-19. DOI: https://doi.org/10.1111/j.1365-3156.2010.02497.x.
19. Erdmann F, Feychting M, Mogensen H, Schmiegelow K, Zeeb H. Social inequalities along the childhood cancer continuum: an overview of evidence and a conceptual framework to identify underlying mechanisms and pathways. Front Public Health. 2019 Apr 18;7:84. DOI: https://doi.org/10.3389/fonc.2018.00485.
20. Kellie SJ, Howard SC. Global child health priorities: what role for paediatric oncologists? Eur J Cancer. 2008 Nov 1;44(16):2388-96. DOI: https://doi.org/10.1016/j.ejca.2008.07.022.
21. Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW, Lacour B, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet. 2004 Dec 11;364(9451):2097-105. DOI: https://doi.org/10.1016/S0140-6736(04)17550-8.